ArticlePloS one2025
Differential cognitive and clinical improvements in Schizophrenia and bipolar disorder following hospitalization: A comparative analysis based on the Clock Drawing Test.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSchizophrenia (SCZ) and bipolar disorder with psychotic features (BDP) are psychiatric disorders with significant impact on affected individuals. However, research comparing cognitive impairments between these groups is limited. This study aimed to evaluate the changes in cognitive function based on the Clock Drawing Test (CDT) among hospitalized SCZ and BDP patients and its association with positive and negative symptoms.
methodsThis cross-sectional study enrolled 84 Iranian patients (42 SCZ, 42 BDP, 51 male and 33 female) aged 42.85 (±11.51), ranging from 20 to 65 years old, from two psychiatric hospitals in Iran. The Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression (CGI) scale and CDT were administered during the admission and discharge of patients. Within-group and between-group changes were analyzed using paired t-tests for pre-post comparisons and multiple regression was used to assess predictive factors of changes in cognitive and symptom changes.
resultsBoth groups showed cognitive and clinical improvements at discharge, but changes were more pronounced in the BDP group for CDT, PANSS-positive symptoms, and CGI. However, PANSS-negative symptoms improved more in SCZ patients. No correlations existed between changes in CDT and positive and negative symptoms in either of the groups.
conclusionWhile both groups exhibited cognitive and clinical improvements following hospitalization, patients with SCZ showed relatively less improvement in the CDT compared to those with BDP. These findings suggest that cognitive recovery may follow a different trajectory in SCZ, independent of changes in positive and negative symptoms but related to the initial cognitive profile. However, given that the CDT is a screening tool rather than a comprehensive cognitive assessment, these results should be interpreted with caution. Future research should incorporate broader neurocognitive assessments to better understand the cognitive trajectories of these populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.